IRIS
MAZZANTI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.043
NA - Nord America 2.852
AS - Asia 2.404
SA - Sud America 349
AF - Africa 107
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.766
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.477
US - Stati Uniti d'America 2.772
CN - Cina 1.061
SG - Singapore 566
IE - Irlanda 499
HK - Hong Kong 278
RU - Federazione Russa 255
BR - Brasile 251
VN - Vietnam 207
NL - Olanda 162
DE - Germania 138
FR - Francia 125
FI - Finlandia 119
GB - Regno Unito 73
IN - India 64
ZA - Sudafrica 57
AR - Argentina 42
CA - Canada 42
BD - Bangladesh 40
SE - Svezia 33
JP - Giappone 30
PL - Polonia 29
MX - Messico 28
UA - Ucraina 28
TR - Turchia 23
AT - Austria 18
PK - Pakistan 15
VE - Venezuela 15
IQ - Iraq 14
MA - Marocco 14
ES - Italia 13
PH - Filippine 12
BE - Belgio 11
ID - Indonesia 11
IR - Iran 11
CO - Colombia 10
EC - Ecuador 10
TN - Tunisia 10
LT - Lituania 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
CZ - Repubblica Ceca 7
UZ - Uzbekistan 7
JO - Giordania 6
KE - Kenya 6
MY - Malesia 6
NP - Nepal 6
AU - Australia 5
BO - Bolivia 5
CL - Cile 5
IL - Israele 5
PE - Perù 5
AZ - Azerbaigian 4
BG - Bulgaria 4
GR - Grecia 4
MD - Moldavia 4
NO - Norvegia 4
PS - Palestinian Territory 4
AM - Armenia 3
CR - Costa Rica 3
ET - Etiopia 3
KZ - Kazakistan 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
KW - Kuwait 2
ML - Mali 2
MU - Mauritius 2
NG - Nigeria 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
BW - Botswana 1
CG - Congo 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
Totale 10.759
Salva come PNG Salva come JPEG
Città #
Dublin 497
Chandler 373
Milan 359
San Jose 298
Ashburn 279
Hong Kong 271
Singapore 270
Beijing 256
Rome 235
Dallas 233
Nanjing 140
Naples 134
Boardman 119
Shanghai 91
Lauterbourg 88
Los Angeles 84
Helsinki 75
Turin 75
Princeton 74
San Genesio Ed Uniti 74
Jacksonville 70
Lawrence 70
Ho Chi Minh City 69
New York 63
Florence 61
Medford 59
Moscow 59
Wilmington 57
Changsha 55
Hanoi 52
Bari 51
Nanchang 51
Johannesburg 48
Palermo 48
Jiaxing 46
Hebei 44
Shenyang 43
Bologna 40
Redondo Beach 39
Tianjin 38
Buffalo 34
Munich 34
Genoa 32
Parma 31
Catania 29
Cagliari 27
Hangzhou 27
Ann Arbor 24
Brescia 24
Orem 22
São Paulo 22
Pavia 20
The Dalles 20
Tokyo 20
Warsaw 20
Chicago 19
Padova 19
Montreal 18
Council Bluffs 17
Pescara 17
Verona 17
Woodbridge 17
Chennai 16
Livorno 16
Norwalk 16
Nuremberg 16
Seattle 16
Turku 16
Frankfurt am Main 15
London 15
Toronto 14
Brooklyn 13
Messina 13
Modena 13
Atlanta 12
Imola 12
Pisa 12
San Francisco 12
Brussels 11
Houston 11
Monserrato 11
Reggio Emilia 11
Stockholm 11
Trieste 11
Haiphong 10
Pomigliano d'Arco 10
Taranto 10
Da Nang 9
Mumbai 9
Phoenix 9
Santa Clara 9
Venice 9
Vienna 9
Falls Church 8
Lahore 8
Manchester 8
Mexico City 8
Reggio Calabria 8
Afragola 7
Baranzate 7
Totale 6.029
Salva come PNG Salva come JPEG
Nome #
Sindrome di Brugada e idoneità alla mansione: case report 3.561
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 182
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 142
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 131
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 130
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 128
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 126
UceWeb: a Web-based Collaborative Tool for Collecting and Sharing Quality of Life Data. 123
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 121
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 119
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 116
Genetic causes of sudden cardiac death in the young. 116
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 115
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death] 114
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 112
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death 110
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 109
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). 109
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 107
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 107
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 103
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 100
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 98
Arrhythmogenic right ventricular cardiomyopathy: Evaluation of the current diagnostic criteria and differential diagnosis 98
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 91
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 90
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 90
The genetics of Long QT Syndrome 89
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 87
Gquest: Modeling patient questionnaires and administering them through a mobile platform application 87
Brugada Syndrome: The Endless Conundrum 86
"Ten Commandments" of 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 86
Usefulness of exercise test in the diagnosis of short QT syndrome 82
Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation: Personalized Medicine for Long QT Syndrome 82
Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome 81
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2 -Catecholaminergic Polymorphic Ventricular Tachycardia 81
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 81
Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy? 81
Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5 80
Brugada syndrome and job fitness: report of three cases 79
Arrhythmic Mitral Valve Prolapse: Introducing an Era of Multimodality Imaging-Based Diagnosis and Risk Stratification. 79
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6) 78
Brugada syndrome and job fitness: report of three cases 76
Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy 75
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 74
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 73
Reply: Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3 72
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain 72
Nonmodifiable Risk Factors Predict Outcomes in Brugada Syndrome 71
Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome 71
Programmed Electrophysiological Stimulation for Risk Prediction in Patients with Brugada Syndrome: Closing Time?,La estimulacion electrica programada para la prediccion del riesgo en pacientes con sindrome de Brugada: ?tiempo de cierre? 70
Molecular Autopsy for Sudden Unexplained Death? Time to Discuss Pros and Cons. 70
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 70
The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome 69
Genetic risk stratification in cardiac arrhythmias 68
Regulatory Light Chain (MYL2) Mutations in Familial Hypertrophic Cardiomyopathy 68
Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia 67
Indications for genetic testing in athletes and its indication in clinical practice 67
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 66
Novel insights in the natural history of Short QT Syndrome 66
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply 66
Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy 64
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility 64
Dilated cardiomyopathy 63
Benefit of Implantable Cardioverter-Defibrillators in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia - Reply 62
Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome 62
Inherited arrhythmias: LQTS/SQTS/CPVT 60
Long-term follow-up of patients with short QT syndrome 60
Transmural APD heterogeneity determines ventricular arrhythmogenesis in LQT8 syndrome: Insights from Bidomain computational modeling 59
Unexpected impairment of INa current underpins reentrant arrhythmias in a knock-in swine model of Timothy syndrome 59
Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene 59
Los estudios genéticos en la prevención de la muerte súbita: ¿realidad o ficción? 59
Is there a role for genetics in the prevention of sudden cardiac death? 59
Repeat adverse events long after percutaneous coronary revascularization in diabetics 59
Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 58
Diagnosis of Long QT Syndrome: Time to Stand Up! 57
Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome 55
Genetic Arrhythmias (Channelopathies) 54
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 53
Warning: Not All Carriers of Pathogenic Mutations in Desmosomal Genes Should Follow the Same Medical Advices! 53
Prevention of Sudden Death and Management of Ventricular Arrhythmias in Arrhythmogenic Cardiomyopathy 52
The new kids on the block of arrhythmogenic disorders: Short QT syndrome and early repolarization 52
Genetic causes of sudden cardiac death in children: inherited arrhythmogenic diseases. 52
Risk Stratification in the Long QT Syndrome 52
Role of CACNA1C in Brugada syndrome: Prevalence and phenotype of probands referred for genetic testing 51
Short QT syndromes 51
Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients 51
Genotype-Phenotype Correlation of SCN5A Genotype in Patients With Brugada Syndrome and Arrhythmic Events: Insights From the SABRUS in 392 Probands 51
Programmed electrophysiological stimulation for risk prediction in patients with Brugada syndrome: closing time? 51
Personalized therapies for cardiac channelopathies 49
The interpretation of genetic tests in inherited cardiovascular diseases 48
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome 47
Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS 43
Induction of ventricular fibrillation during programmed ventricular stimulation in a patient with CASQ2 heterozygous mutation 27
Totale 10.914
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.835
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 17 9 3
2021/2022321 0 7 14 0 7 13 3 19 15 24 46 173
2022/20231.174 146 92 19 69 86 101 0 54 564 3 25 15
2023/20241.841 62 86 94 175 182 257 199 168 67 177 162 212
2024/20252.950 276 188 154 197 145 229 225 262 524 168 222 360
2025/20263.619 364 239 456 430 483 148 648 219 363 269 0 0
Totale 10.914